Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

24 September 2024

Industry Investors Make Case for Paris-like AMR Guidance

In an article for ESG Investor on investors’ efforts in the fight against AMR, Alice Tchernookova interviewed Suzi van Es, the Foundation’s Investor Engagement Manager.

Direct links

Read the full article

The article highlights the urgent threat of AMR and the important role of investors in tackling this global challenge. It discusses the renewed calls for global alignment from 80 global investors, urging world leaders to adopt a unified, evidence-based approach to combat AMR. Building on a statement released in May, the investors highlight the critical need for global cooperation, sustained funding, and innovative solutions. They warn that without significant action, AMR could result in substantial economic losses and millions of deaths.  

“With growing resistance, time is running out. You could even say we’ve run out of time,” The article quotes Suzi van Es, Investor Engagement Manager at the Foundation, “People need to be action oriented. This is about us achieving right now – rather than mapping or understanding roles and responsibilities.” 

Resource Centre

Explore our research reports and publications
Featured Research

How can pharma get the few promising drugs in development to patients battling superbugs?

23 May 2024
Media

Faced with fewer superbug-beating drugs, how can pharma get more promising medicines to patients?

28 May 2024

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved